Suppr超能文献

印度艾滋病毒/艾滋病患者的医疗服务经济负担。

Financial burden of health services for people with HIV/AIDS in India.

作者信息

Kumarasamy N, Venkatesh K K, Mayer K H, Freedberg Kenneth

机构信息

YRG Centre for AIDS Research & Education, Voluntary Health Services, Chennai, Tamil Nadu, India.

出版信息

Indian J Med Res. 2007 Dec;126(6):509-17.

Abstract

In resource-limited settings, illness can impose a major financial burden on patients and their families. With the advent and increasing accessibility of antiretroviral therapy, HIV/AIDS has now become a fundamentally chronic treatable disease with far reaching economic and social consequences, and hence it is crucial to also examine the long-term financial impact of HIV healthcare. Beyond the direct costs of medications, monitoring, and medical care, additional costs include the long-term lost earnings of HIV-infected individuals as well as of their household members who also provide care. A clearer understanding of the financial burden of healthcare for HIV-infected Indians can allow policy makers and planners to better allocate limited resources. This article reviews the financial consequences of HIV care and treatment on individuals and their households by examining current treatment options, HIV monitoring, the clinical course of HIV disease, and the roles of the private and public sector in providing HIV care in India. Future studies should more thoroughly examine the financial impact of HIV-related costs incurred by households over time and examine household responses to these costs.

摘要

在资源有限的环境中,疾病会给患者及其家庭带来巨大的经济负担。随着抗逆转录病毒疗法的出现及其可及性的提高,艾滋病毒/艾滋病现已成为一种基本上可长期治疗的慢性疾病,具有深远的经济和社会影响,因此,审视艾滋病毒医疗保健的长期经济影响也至关重要。除了药物、监测和医疗护理的直接成本外,额外成本还包括艾滋病毒感染者及其提供护理的家庭成员的长期收入损失。更清楚地了解印度艾滋病毒感染者的医疗保健经济负担,有助于政策制定者和规划者更好地分配有限资源。本文通过研究当前的治疗选择、艾滋病毒监测、艾滋病毒疾病的临床病程以及印度私营和公共部门在提供艾滋病毒护理方面的作用,回顾了艾滋病毒护理和治疗对个人及其家庭的经济影响。未来的研究应更全面地审视家庭随着时间推移产生的与艾滋病毒相关成本的经济影响,并研究家庭对这些成本的应对措施。

相似文献

2
Costs and financial burden of care and support services to PLHA and households in South India.
AIDS Care. 2006 Feb;18(2):121-7. doi: 10.1080/09540120500159359.
3
Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting.
HIV Med. 2013 Feb;14(2):120-4. doi: 10.1111/j.1468-1293.2012.01034.x. Epub 2012 Jul 10.
5
The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.
BMC Health Serv Res. 2017 Jan 24;17(1):76. doi: 10.1186/s12913-017-1976-y.
6
Engaging the private sector to increase access to HIV services and increase sustainability of the HIV response.
BMC Health Serv Res. 2025 May 28;24(Suppl 1):1672. doi: 10.1186/s12913-025-12530-1.
8
The price of progress: Assessing the financial costs of HIV/AIDS management in East Africa.
Medicine (Baltimore). 2025 May 2;104(18):e42300. doi: 10.1097/MD.0000000000042300.
9
The cost effectiveness of combination antiretroviral therapy for HIV disease.
N Engl J Med. 2001 Mar 15;344(11):824-31. doi: 10.1056/NEJM200103153441108.
10
Economic impact of HIV.
Best Pract Res Clin Obstet Gynaecol. 2005 Apr;19(2):197-210. doi: 10.1016/j.bpobgyn.2004.10.005. Epub 2004 Dec 13.

引用本文的文献

1
Ethical Considerations for Engaging Youth Living with HIV in Research: Perspectives from Youth, Their Caregivers and Subject Matter Experts in Kenya.
J Empir Res Hum Res Ethics. 2023 Oct;18(4):175-188. doi: 10.1177/15562646231193949. Epub 2023 Aug 13.
2
Awareness and Hesitancy of COVID-19 and other Vaccines among People Living with HIV/AIDS Attending Antiretroviral Therapy (ART) Center in North India.
Indian J Community Med. 2023 May-Jun;48(3):492-496. doi: 10.4103/ijcm.ijcm_901_22. Epub 2023 May 30.
3
Determinants and economic burden of HIV/AIDS in Iran: a prospective study.
BMC Health Serv Res. 2023 Mar 14;23(1):251. doi: 10.1186/s12913-023-09229-6.
7
Out-of-pocket expenditures for HIV in the Dominican Republic: findings from a community-based participatory survey.
Rev Panam Salud Publica. 2019 Jun 7;43:e56. doi: 10.26633/RPSP.2019.56. eCollection 2019.
8
The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.
BMC Health Serv Res. 2017 Jan 24;17(1):76. doi: 10.1186/s12913-017-1976-y.

本文引用的文献

1
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
AIDS. 2007 Jul;21 Suppl 4(Suppl 4):S117-28. doi: 10.1097/01.aids.0000279714.60935.a2.
2
'Where is the public health sector?' Public and private sector healthcare provision in Madhya Pradesh, India.
Health Policy. 2007 Dec;84(2-3):269-76. doi: 10.1016/j.healthpol.2007.04.004. Epub 2007 May 30.
7
HIV in India--a complex epidemic.
N Engl J Med. 2007 Mar 15;356(11):1089-93. doi: 10.1056/NEJMp078009.
10
Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
Sex Transm Dis. 2006 Oct;33(10 Suppl):S145-52. doi: 10.1097/01.olq.0000238457.93426.0d.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验